Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Psychiatry and Mental health
Reference39 articles.
1. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.;Rogers;Am J Med,2002
2. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity.;Ingelman-Sundberg;Pharmacogenomics J,2005
3. Clinical guidelines for using pharmacogenetic testing of CYP450 2D6 and CYP450 2C19 in psychiatry.;de Leon;Psychosomatics,2006
4. A poor metabolizer for both Cytochrome P450 2D6 and 2C19 (CYP2D6 and CYP2C19): a case report on antidepressant treatment.;Johnson;CNS Spectr,2006
5. CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.;Alfaro;J Clin Psychopharmacol,1999
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献